|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Dengue Virus IgG ELISA | Acid Labile Subunit (ALS) ELISA Assay | Anti-Trastuzumab (Herceptin®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Vasoactive Intestinal Polypeptide (VIP) RIA |
| Catalog Number | IB05044 | E35 | TM09015 | TM09036 | RB311RUO |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgG antibodies directed against Dengue virus in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of Acid Labile Subunit (ALS) in serum and plasma (heparin, EDTA, citrate). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Trastuzumab (Herceptin®, Herclon®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Radioimmunoassay (RIA) for the determination of Vasoactive Intestinal Polypeptide (VIP) in human plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Dengue Virus IgG | Immunoglobulin A (IgA) | Ranibizumab (Lucentis®) (mAb-based) | sAPP Total | Vasoactive Intestinal Polypeptide (VIP) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum, plasma, tissue homogenates and other biological fluids. | Aqueous humour | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 1.5 to 40.0 mU/mL ALS | 0 / 30 - 1000 ng/mL | Anti-Ustekinumab (Stelara®) | 3.8 to 120 pmol/L |
| Sensitivity | > 96% | 0.469 ng/ml | 0.33 ng/mL | 0.06 ng/mL | 3 pmol/L |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 3 hrs (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 48 hrs 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |